Kenvue EV/OCF

What does Kenvue do? Kenvue Inc, listed under ticker KVUE with ISIN US49177J1025, is a consumer health company headquartered in Skillman, New Jersey. The company has 22,000 employees and completed its IPO on May 4, 2023. Kenvue operates through three business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment encompasses product categories such as cough, cold, and allergy remedies, pain care, and other self-care solutions including digestive health, smoking cessation, and more. The Skin Health and Beauty segment includes face and body care, hair care, sun care, and related products. The Essential Health segment covers oral care, baby care, and other essential health categories like women’s health and wound care. Kenvue’s portfolio features well-known brands such as Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The company distributes its products globally, reaching over 165 countries across four regions. Its distribution network comprises 114 distribution centers and 38 customer service centers worldwide. Kenvue is categorized under the Consumer Staples sector within the Consumer Products industry. The company’s operations reflect a focus on health and personal care products, serving diverse consumer needs through a broad portfolio of trusted brands. Kenvue is one of the most popular companies on Eulerpool.